SINTX TECHNOLOGIES HIRES STRATEGIC VP
April 15 2019 - 09:00AM
SINTX Technologies, Inc. (NASDAQ: SINT) announced today that it has
hired Donald J. Bray as Vice President of Business Development. Mr.
Bray was formerly Vice President of Technology at Morgan Advanced
Materials, where he focused on leading strategic initiatives into
new market areas. Mr. Bray will assume the new role at SINTX on 22
April 2019.
“Silicon nitride is among the most advanced
ceramic materials”, said Dr. Sonny Bal, Chairman and CEO of SINTX
Technologies, “with applications across many industries. In
addition to being approved for highly-demanding medical device
applications, our formulation of silicon nitride has been
characterized, validated, and tested extensively through a robust
R&D program, and is fully competitive with industrial
formulations required, for example, by the aerospace and defense
industries. With the addition of Don, SINTX is well-positioned to
focus on markets outside medical devices.”
“As SINTX explores new sources of OEM revenue
and new partnerships inside and outside of health care, Don’s
extensive background and experience in technical ceramics and
business development are particularly relevant. In addition, Don
has a proven track record of securing federal, state, and local
funds in support of technology development; these skills will help
SINTX continue a strategic pivot toward positioning its silicon
nitride and related ceramic technologies for a broad range of
medical and non-medical applications,” added Dr. Bal.
“I am thrilled to be part of the SINTX team”,
said Mr. Bray. “My entire career has been spent in the advanced
materials industry and I look forward to continuing that work in
helping SINTX grow. They have a strong technology and manufacturing
suite with many potential applications.”
A photo accompanying the release is
available http://www.globenewswire.com/NewsRoom/AttachmentNg/0527a2a4-dd28-4a76-895e-a133d0e405b6
About SINTX Technologies
SINTX Technologies is an OEM ceramics company
that develops and commercializes silicon nitride for biomedical
applications, such as spine and dental implants. The core strength
of SINTX Technologies is the research and development of
medical-grade silicon nitride ceramics for external partners. The
Company presently manufactures silicon nitride spinal implants in
its ISO 13485 certified manufacturing facility for CTL-Amedica, the
exclusive retail channel for silicon nitride spinal implants.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 (“PSLRA”) that are subject to a number of risks
and uncertainties. Readers are cautioned not to place undue
reliance on the forward-looking statements, which speak only as of
the date on which they are made and reflect management’s current
estimates, projections, expectations and beliefs. A discussion of
those risks and uncertainties can be found in SINTX's Risk Factors
disclosure in its Annual Report on Form 10-K, filed with the
Securities and Exchange Commission (SEC) on March 11, 2019, and in
SINTX's other filings with the SEC. SINTX disclaims any obligation
to update any forward-looking statements. SINTX undertakes no
obligation to publicly revise or update the forward-looking
statements to reflect events or circumstances that arise after the
date of this report.
For more information on SINTX Technologies or
its silicon nitride material platform, please visitwww.sintx.com.
Contact:
SINTX Technologies 801-839-3502 IR@sintx.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Feb 2024 to Mar 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Mar 2023 to Mar 2024